We’re excited to announce that CMR Surgical has been granted U.S. FDA Marketing Authorization for the use of #Versius in Cholecystectomy. The FDA marketing authorization of #Versius is a significant milestone, with Versius being the first multi-port, soft tissue general surgical Robotic Assisted Surgical Device (RASD) to successfully be authorized through FDA’s De Novo application process. Versius is a RASD intended to assist in the precise and accurate control of Versius Surgical endoscopic instruments and is indicated in the U.S. for adult patients 22 years of age and older, eligible for soft tissue minimal access surgery, for cholecystectomy. Read more: https://lnkd.in/eKWPjD4Y #CMRSurgical #TransformingSurgery
While we are doing top notch complicated surgery with CMR including esophagectomy and prostatectomy with CMR...... !!!! Only Cholecystectomy there;!!
Congratulations!
Congratulations team. Great news. 👏👏👏
Amazing news!! 😁😁😁
Congrats to the whole CMR team and everyone involvement. Well done!
Congratulations to all who worked on the project. Very much deserved 👏👏👏
Great news 👏🏽
This news comes to crown a job well done and a quality robotics system. Congratulations to everyone involved.!!!!!!👏 👏 👏 👏
Congrats!
New Business Commercial Executive at #CMRSurgical. Transforming surgery. For good.
4moA proud day 🦾 what an achievement for the whole team past and present